Metoprolol Succinate Tablet, Extended Release
Product Images NDC 72516-032

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Metoprolol Succinate (NDC 72516-032). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Oryza Pharmaceuticals, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Spl-figure-01 (Spl Figure 01)

Chemical structure diagram of Metoprolol Succinate showing the molecular arrangement including functional groups such as hydroxyl, ether, amine, and carboxyl groups.*

FDA Label Image

Spl-figure-02 (Spl Figure 02)

A forest plot chart titled 'Results for Subgroups in MERIT-HE' comparing Metoprolol Succinate Extended-Release Tablets to placebo. The chart displays relative risk and 95% confidence intervals for subgroups on endpoints including Total Mortality, Total Mortality or All-Cause Hospitalization, and Total Mortality or Hospitalization for Heart Failure. Subgroups listed include regions (US, Non-US), NYHA classifications, ejection fraction categories, etiologies, sex, race, prior conditions, diabetes status, hypertension status, and heart rate groups.*

FDA Label Image

Spl-figure-04 (Spl Figure 04)

Metoprolol Succinate Extended-Release Tablets 25 mg in a package containing 100 tablets. The label includes storage instructions, warning to keep out of children's reach, and manufacturer details: Oryza Pharmaceuticals, Inc. and Visum Pharmaceutical Co., Ltd. The label displays the NDC number 72516-030-01 and a barcode.*

FDA Label Image

Spl-figure-05 (Spl Figure 05)

Metoprolol Succinate Extended-Release Tablets 50 mg, oral dosage form, with 100 tablets per package. Label shows dosing information, storage instructions, warning to keep out of reach of children, and manufacturing details. Labeler is Oryza Pharmaceuticals, Inc.*

FDA Label Image

Spl-figure-06 (Spl Figure 06)

Metoprolol Succinate Extended-Release Tablets packaging label showing 100 mg strength with a count of 100 tablets. Label includes storage instructions and warnings, manufactured by Visum Pharmaceutical Co., Ltd., and labeled by Oryza Pharmaceuticals, Inc. The label features the NDC 72516-032-01 and barcode.*

FDA Label Image

Spl-figure-07 (Spl Figure 07)

Label for Metoprolol Succinate Extended-Release Tablets, 200 mg strength, in a package containing 100 tablets. The label includes storage information, manufacturer and labeler details (Oryza Pharmaceuticals, Inc and Visum Pharmaceutical Co., Ltd), and a barcode. The labeler is Oryza Pharmaceuticals, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.